NO20015848L - Polymorfer av et krystallinsk azabicyclo(2,2,2)oktan-3- amincitrat og farmasöytiske preparater derav - Google Patents

Polymorfer av et krystallinsk azabicyclo(2,2,2)oktan-3- amincitrat og farmasöytiske preparater derav

Info

Publication number
NO20015848L
NO20015848L NO20015848A NO20015848A NO20015848L NO 20015848 L NO20015848 L NO 20015848L NO 20015848 A NO20015848 A NO 20015848A NO 20015848 A NO20015848 A NO 20015848A NO 20015848 L NO20015848 L NO 20015848L
Authority
NO
Norway
Prior art keywords
polymorphs
octane
pharmaceutical preparations
amine citrate
azabicyclo
Prior art date
Application number
NO20015848A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015848D0 (no
Inventor
Michael James Castaldi
George Joseph Quallich
Lewin Theophilus Wint
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20015848D0 publication Critical patent/NO20015848D0/no
Publication of NO20015848L publication Critical patent/NO20015848L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20015848A 1999-06-01 2001-11-30 Polymorfer av et krystallinsk azabicyclo(2,2,2)oktan-3- amincitrat og farmasöytiske preparater derav NO20015848L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01
PCT/IB2000/000665 WO2000073304A1 (en) 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO20015848D0 NO20015848D0 (no) 2001-11-30
NO20015848L true NO20015848L (no) 2001-12-18

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015848A NO20015848L (no) 1999-06-01 2001-11-30 Polymorfer av et krystallinsk azabicyclo(2,2,2)oktan-3- amincitrat og farmasöytiske preparater derav

Country Status (48)

Country Link
US (1) US6255320B1 (cs)
EP (1) EP1181290B1 (cs)
JP (1) JP3830816B2 (cs)
KR (1) KR100476606B1 (cs)
CN (1) CN1146565C (cs)
AP (1) AP2001002349A0 (cs)
AR (1) AR033331A1 (cs)
AT (1) ATE244239T1 (cs)
AU (1) AU767334B2 (cs)
BG (1) BG65240B1 (cs)
BR (1) BR0011094A (cs)
CA (1) CA2372238C (cs)
CO (1) CO5170463A1 (cs)
CY (1) CY2007011I1 (cs)
CZ (1) CZ295819B6 (cs)
DE (1) DE60003679T2 (cs)
DK (1) DK1181290T3 (cs)
DZ (1) DZ3050A1 (cs)
EA (1) EA003731B1 (cs)
EC (1) ECSP003508A (cs)
EE (1) EE200100656A (cs)
ES (1) ES2199825T3 (cs)
GT (1) GT200000087A (cs)
HN (1) HN2000000077A (cs)
HR (1) HRP20010904A2 (cs)
HU (1) HUP0201301A3 (cs)
IL (1) IL146406A0 (cs)
MA (1) MA26742A1 (cs)
MX (1) MXPA01012325A (cs)
MY (1) MY133508A (cs)
NO (1) NO20015848L (cs)
NZ (1) NZ515349A (cs)
OA (1) OA11956A (cs)
PA (1) PA8496101A1 (cs)
PE (1) PE20010209A1 (cs)
PL (1) PL196046B1 (cs)
PT (1) PT1181290E (cs)
SI (1) SI1181290T1 (cs)
SK (1) SK285820B6 (cs)
SV (1) SV2001000093A (cs)
TN (1) TNSN00120A1 (cs)
TR (1) TR200103473T2 (cs)
TW (1) TWI285204B (cs)
UA (1) UA66925C2 (cs)
UY (1) UY26176A1 (cs)
WO (1) WO2000073304A1 (cs)
YU (1) YU81101A (cs)
ZA (1) ZA200109775B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1713504T1 (sl) * 2004-01-30 2017-10-30 Zoetis Services Llc Protimikrobni konzervansi za dosego večodmerne formulacije z uporabo beta-ciklodekstrinov za tekoče odmerne oblike
BRPI0507301A (pt) * 2004-01-30 2007-06-26 Pfizer Prod Inc composições farmacêuticas de antagonistas do receptor de nuerocinina e ciclodextrina e métodos para melhor toleráncia no local de injeção
BRPI0507325A (pt) * 2004-01-30 2007-07-03 Pfizer Prod Inc antagonistas dos receptores nk-1 para melhorar a recuperação da anestesia
DE602005003791T2 (de) * 2004-02-02 2008-05-29 Pfizer Products Inc., Groton Verfahren zur herstellung von 1-(2s,3s)-2-benzhydril-n-(5-tert.-butyl-2-methoxybenzyl)chinuklidin-3-amin
RU2696582C2 (ru) * 2013-03-15 2019-08-05 Перл Терапьютикс, Инк. Способы и системы кондиционирования дисперсных кристаллических материалов
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法
CN112979639B (zh) * 2019-12-16 2025-08-08 凯默斯医药科技(上海)有限公司 一种马罗皮坦新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2102179C (en) * 1991-05-31 1998-10-27 Fumitaka Ito Quinuclidine derivatives
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
EE200100656A (et) 2003-02-17
ATE244239T1 (de) 2003-07-15
NO20015848D0 (no) 2001-11-30
HN2000000077A (es) 2001-02-02
PA8496101A1 (es) 2002-07-30
SK17332001A3 (sk) 2002-07-02
TNSN00120A1 (fr) 2005-11-10
CA2372238A1 (en) 2000-12-07
JP2003501354A (ja) 2003-01-14
AP2001002349A0 (en) 2001-12-31
PE20010209A1 (es) 2001-03-01
GT200000087A (es) 2001-11-22
TR200103473T2 (tr) 2002-04-22
CZ20014269A3 (cs) 2002-04-17
SV2001000093A (es) 2001-11-08
SK285820B6 (sk) 2007-09-06
US6255320B1 (en) 2001-07-03
TWI285204B (en) 2007-08-11
MXPA01012325A (es) 2002-07-22
MA26742A1 (fr) 2004-12-20
YU81101A (sh) 2004-07-15
ECSP003508A (es) 2002-02-25
CA2372238C (en) 2006-12-19
AR033331A1 (es) 2003-12-17
EP1181290A1 (en) 2002-02-27
AU767334B2 (en) 2003-11-06
IL146406A0 (en) 2002-07-25
MY133508A (en) 2007-11-30
CO5170463A1 (es) 2002-06-27
KR100476606B1 (ko) 2005-03-18
PL196046B1 (pl) 2007-11-30
EA200101108A1 (ru) 2002-04-25
BR0011094A (pt) 2002-03-19
CN1353711A (zh) 2002-06-12
DK1181290T3 (da) 2003-09-29
EA003731B1 (ru) 2003-08-28
JP3830816B2 (ja) 2006-10-11
CN1146565C (zh) 2004-04-21
PT1181290E (pt) 2003-09-30
AU4424800A (en) 2000-12-18
CY2007011I2 (el) 2010-07-28
CY2007011I1 (el) 2010-07-28
DE60003679T2 (de) 2004-05-27
EP1181290B1 (en) 2003-07-02
ES2199825T3 (es) 2004-03-01
SI1181290T1 (en) 2003-12-31
HK1046284A1 (en) 2003-01-03
DZ3050A1 (fr) 2004-03-27
PL352716A1 (en) 2003-09-08
UA66925C2 (uk) 2004-06-15
DE60003679D1 (de) 2003-08-07
WO2000073304A1 (en) 2000-12-07
HRP20010904A2 (en) 2003-02-28
BG65240B1 (bg) 2007-09-28
HUP0201301A2 (en) 2002-08-28
NZ515349A (en) 2004-03-26
UY26176A1 (es) 2000-12-29
HUP0201301A3 (en) 2002-10-28
ZA200109775B (en) 2002-11-28
BG106204A (en) 2002-07-31
CZ295819B6 (cs) 2005-11-16
OA11956A (en) 2006-04-13
KR20020010688A (ko) 2002-02-04

Similar Documents

Publication Publication Date Title
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
NO20002721L (no) Heterocykliske forbindelser for inhibering av mavesyresekresjon, fremgangsmÕter for deres fremstilling og farmasøytiske preparater derav
IS5070A (is) Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það
NO20021701D0 (no) Fremgangsmåte for fremstilling av et konjugat av polyglutamat og et terapeutisk middel
NO20002835D0 (no) 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor
IS5245A (is) Lyfjablanda úr ómeprasól
NO20000435L (no) Oralt farmasoytisk preparat omfattende en forbindelse med anti-ulceraktivitet og fremgangsmate for dets fremstilling
NO20014220L (no) <Kappa>-agonist-forbindelser og farmasöytiske preparater derav
NO20013560L (no) Polymorfer av telmisartan, fremgangsmåter for fremstilling derav og anvendelse derav for fremstilling av et medikament
NO20016277D0 (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske formuleringer
NO20005430L (no) 1-[(1-substituerte-4-piperidinyl)metyl]-4-piperidinderivater, fremgangsmåter for fremstilling av disse, medisinske preparater inneholdende disse, og mellomprodukter for disse forbindelser
NO20001409L (no) Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
AP2000001829A0 (en) Substituted thiazolidinedione derivative process for its preparation and its pharmaceutical use
NO20006576D0 (no) Et substituert triazol-pyridazinderivat og farmasöytiske preparater fremstilt av dette
CY2007011I2 (el) Πολυμορφες ενος κρυσταλλικου κιτρικου αλατος αζαδικυκλο (2,2,2) οκταν -3- αμινης και φαρμακευτικες συνθεσεις τους
NO20001909L (no) FremgangsmÕte og anlegg for fremstilling av 1,2-dikloretan
FR2793688B1 (fr) Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
NO20013878L (no) (1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparaterinneholdende de samme
IS6159A (is) Fjölgervingar af kristölluðu asabísýkló (2,2,2) oktan-3-amín sítrati og lyfjasamsetningar
NO20020777D0 (no) Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav
NO20014051D0 (no) Fremgangsmate for fremstilling av et noringsmiddel
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
NO305084B1 (no) Propansyrederivater, medikament og farmas°ytisk preparat inneholdende et slikt derivat
SI1090029T1 (en) 14,15-cyclopropanosteroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds
ES1042357Y (es) "columna modular perfeccionada".

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application